While the inactivation of VHL is considered the rate-limiting event in carcinogenesis, the majority of ccRCC tumors also contain deletions of the genomic loci of PBRM1, SETD2, and/or BAP12,3. Here, SETD2 is linked to nonpapillary renal cell carcinoma.